Stress is one of the main causes of health damage, especially the biggest risk factor for cardiovascular disease, causing ...

In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), invasive ...

Early data from the prethrombolytic and thrombolytic eras suggest that in the setting of AMI, LV thrombus was present in 7–46% of patients, most frequently in acute anterior or apical myocardial ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Myocardial infarction, commonly known as a heart attack, is a critical cardiovascular event with significant implications and occurs when the blood flow to a part of the heart muscle is obstructed ...

Clinical studies that have used type 2 myocardial infarction as a diagnostic criterion have produced disparate incidence figures. The range of associated clinical conditions differs from study to ...

ecu.edu.au In this paper, we discuss and critically analyse pre-hospital management of acute myocardial infarction (AMI). It is clear from several large studies that rapid diagnosis and application of ...

The association between hospital-diagnosed migraine and increased risks to cardiovascular health cannot be attributed to NSAID use.

Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is ...

Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 ...

Inspra (eplerenone tablets; Pfizer, Inc., New York, NY) is an aldosterone blocker that works by binding at the mineralocorticoid receptor. It has some similarities to the potassium-sparing ...

Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...